Results 221 to 230 of about 25,888 (267)

Neurovascular compression in patients with stress-related somatic complaints.

Ind Psychiatry J
Zahoor B, Chadha G, Sekhon S, Jose NA, Bhatia MS.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Dual serotonin and noradrenaline reuptake inhibitors: Focus on their differences

International Journal of Psychiatry in Clinical Practice, 2006
There are three non-tricyclic dual serotonin (5-HT) and noradrenaline (NA) reuptake inhibitors (SNRIs) currently used in human therapeutics for psychiatric disorders. These medications differ in their in vitro potency to inhibit 5-HT and NA reuptake with differential ratios of activity.
Pierre Blier
exaly   +3 more sources

Effect of combined treatment with noradrenaline and serotonin reuptake inhibitors on conditioned freezing

European Journal of Pharmacology, 2006
To clarify the therapeutic interaction between serotonin and noradrenaline reuptake inhibition on fear, this study examined the acute and subchronic effects of combined treatment with the selective serotonin reuptake inhibitor citalopram and the selective noradrenaline reuptake inhibitor reboxetine on the expression of conditioned fear (re-exposure to ...
Takeshi Inoue, Shin Nakagawa, Takeshi Izumi   +2 more
exaly   +3 more sources

Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex

Naunyn-Schmiedeberg's Archives of Pharmacology, 2003
Some clinical reports suggest that tricyclic antidepressants which block both noradrenaline and serotonin (5-HT) reuptake (SNRIs) are more effective than selective 5-HT reuptake inhibitors (SSRIs) in treating severe depression. Moreover, one neurochemical study reported larger increases in extracellular 5-HT in rat frontal cortex in response to the ...
Stephan Hjorth, Sidney B Auerbach
exaly   +3 more sources

Serotonin noradrenaline reuptake inhibitors: New hope for the treatment of chronic pain

International Journal of Psychiatry in Clinical Practice, 2006
Depression and painful symptoms occur frequently together. Over 75% of depressed patients report painful symptoms such as headache, stomach pain, neck and back pain as well as non-specific generalized pain. In addition, World Health Organization data have shown that primary care patients with chronic pain have a four fold greater risk of becoming ...
Pedro L Delgado
exaly   +3 more sources

Exposure to serotonin selective reuptake inhibitors or serotonin noradrenaline reuptake inhibitors and sexual dysfunction: Results from an online survey

International Journal of Risk & Safety in Medicine, 2021
BACKGROUND: Post-SSRI Sexual Dysfunction (PSSD) is characterized by sexual and emotional symptoms associated to the exposure to Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Noradrenaline Reuptake Inhibitors (SNRI). OBJECTIVE:
Patacchini, Arianna, Cosci, Fiammetta
openaire   +2 more sources

The discovery of 071031B, a novel serotonin and noradrenaline reuptake inhibitor

Neuroscience Letters, 2013
Depression is a severe mood disorder with increasing morbidity and suicidality, while the current therapy is not satisfactory. Serotonin and noradrenaline reuptake inhibitors (SNRIs) have been reported to have higher efficacy and/or faster acting rate than commonly used antidepressants.
Rui, Xue, Yan-Ping, Zhang, Zeng-Liang, Jin, Li, Yuan, Xin-Hua, He, Nan, Zhao, Hong-Xia, Chen, Li-Ming, Zhang, Shi-Yong, Fan, Bo-Hua, Zhong, You-Zhi, Zhang, Yun-Feng, Li   +11 more
openaire   +2 more sources

Milnacipran, a new specific serotonin and noradrenaline reuptake inhibitor

Drugs of Today, 1998
Milnacipran is a new antidepressant which inhibits equipotently the reuptake of serotonin and noradrenaline both in vitro and in vivo with no effect on dopamine reuptake. Microdialysis studies have shown increased extracellular levels of both serotonin and noradrenaline after acute administration.
P, Boyer, M, Briley
openaire   +2 more sources